VV261

VV261 is an orally active Influenza Virus inhibitor. VV261 has demonstrated activity against severe febrile thrombocytopenia syndrome virus (SFTSV) and lymphocytic choriomeningitis virus (LCMV) (EC50: 0.89 and 0.15, respectively) [1].

Product Specifications

CAS Number

[3003864-86-3]

UNSPSC

12352005

Target

Influenza Virus

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

O=C(C1=CC=CN=C1)OCN2C(N(C=CC2=O)[C@@H]3O[C@@](COC(C(C)C)=O)(F)[C@@H](OC(C(C)C)=O)[C@H]3OC(C(C)C)=O)=O

Molecular Formula

C28H34FN3O11

Molecular Weight

607.58

References & Citations

[1]Cheng Y, et al. Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSV. J Med Chem. 2025 May 8;68 (9) :9811-9826.